Discover how pre-stratification enables you to reduce clinical trial size without sacrificing statistical power.

Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...

Paracentral acute middle maculopathy is a highly specific OCT marker for biopsy-proven giant cell arteritis with ocular ischemic involvement.

Enbridge boasts robust fundamentals, a healthy balance sheet, and a clear path to mid-single-digit DCF and EBITDA growth beyond 2026. Read why ENB stock is a hold.

Elevated oil/gasoline prices with upside risk may turn sugar as key geopolitical commodity this year and next, says Michael Ferrari of Moby and AlphaGeo ...

KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment$108 million in cash provides runway into the second half of 2028, through ...

Each of these transactions leave a data trail. Artificial intelligence is increasingly analysing this data to influence how consumers discover credit, compare financial products and manage repayment r ...

KOMODO-1 first-in-human clinical trial of BBI-940 open for enrollment $108 million in cash provides runway into the second half of 2028, through expected clinical proof-of-concept readout for KOMODO-1 ...

By\xa0 Samuel Ohene NyantakyiIn the bustling markets of Accra and Kumasi’s Kejetia, where traders shout prices and customers haggle for the best deals, there is an unexpected new contender entering ...

Although the Graves disease treatment landscape remains challenging, emerging therapies could shift existing treatment ...

Presented data at ESMO 2025 demonstrating promising efficacy with CRB-701 in head and neck squamous cell carcinoma (HNSCC) ...

Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome, expected to initiate ...